Clinical Study to Evaluate the RxSight Light Adjustable Lens With the Light Delivery Device in Subjects With Preoperative Corneal Astigmatism

Inclusion criteria

• Must sign a written Informed Consent form and be willing to undergo cataract surgery for the bilateral implantation of the RxLAL.
• Greater than the age of 40 on the day the cataract surgery is performed.
• Preoperative keratometric cylinder of >=0.50 D and <=4.00 D in both eyes.
• Cataract causing reduction in best corrected distance visual acuity (BCDVA) to a level of 20/32 or worse with or without glare source in both eyes.
• Willing and able to comply with the requirements for study specific procedures and visits.

Exclusion criteria

• Zonular laxity or dehiscence.
• Age-related macular degeneration involving the presence of geographic atrophy or soft drusen.
• Retinal degenerative disorder or macular disorder (other than mild macular degeneration) that is expected to cause future vision loss.
• History of uveitis
• Keratoconus or suspected of having keratoconus.
• Previous corneal or intraocular surgery, except eyes with previous pterygium excision are permitted as long as the pterygium did not extend more than 2mm onto the cornea from the limbus.
• Serious co-morbid conditions that in the judgement of the investigator makes inclusion in the study not in the best interest of the subject.
• Subjects taking systemic medications that may increase sensitivity to UV light.
• Subjects taking a systemic medication that is considered toxic to the retina such as tamoxifen.
• History of ocular herpes simplex virus
• History of congenital color vision defect